FURTHER STUDIES OF THE PHARMACOLOGY OF THE PYLORIC REGION: ANALYSIS OF THE EFFECTS OF INTRA-ARTERIAL HISTAMINE, SEROTONIN, PHENYLDIGUANIDE, MORPHINE, AND OTHER DRUGS ON THE ANTRUM AND DUODENAL BULB

1966 ◽  
Vol 44 (6) ◽  
pp. 981-1019 ◽  
Author(s):  
E. E. Daniel

The actions of drugs on the antrum and duodenum of the dog were analyzed by the use primarily of intra-arterial injections into the gastroepiploic artery while the electrical and contractile activity of these regions was recorded. Histamine (0.1 to 5 μg) usually caused excitation of second potentials (antrum) or fast spikes (duodenum), and contractions (both) and other effects similar to those produced by acetylcholine, though usually delayed in onset and more prolonged. Its effects were diminished or prevented by atropine, nicotine, and hexamethonium as well as by antihistaminics such as antazoline, cyproheptadine, and phenoxybenzamine. In the duodenum, histamine excitation was usually preceded by inhibition, and most antihistaminics also depressed responses to serotonin (5-HT), acetylcholine, or both. Low doses of serotonin (0.1 to 1 μg) most frequently caused excitation of the antrum and duodenum similar to that evoked by acetylcholine. This response was sometimes prolonged. These effects in the antrum were diminished or prevented by atropine, nicotine, methysergide, and bromolysergic acid (BOL), and less effectively antagonized by hexamethonium, morphine, and pronethalol. Phenoxybenzamine did not prevent excitation of the antrum by low doses of 5-HT, but tachyphylaxis following high doses of 5-HT (5 to 100 μg) or of phenyldiguanide (25 to 500 μg) did prevent such responses. Several of these agents also inhibited excitation of the duodenum induced by 5-HT and cross tachyphylaxis between 5-HT and phenyldiguanide was also observed. It was suggested that low doses of 5-HT, like phenyldiguanide, acted at a preganglionic site in the antrum and duodenum different from that at which histamine acts, presumably the non-medullated mucosal mechanoreceptors, and ultimately caused release of acetylcholine from postganglionic fibers. Phenyldiguanide in small doses (2 to 25 μg) acted like 5-HT to excite the antrum and duodenum. Analysis of its action with antagonists yielded results similar to those with 5-HT, and the occurrence of cross tachyphylaxis with 5-HT suggested a common site of action. Morphine (10 to 1000 μg) usually inhibited electrical and contractile activity in the antrum and stimulated these activities in the duodenum. The same results were obtained with intravenous injection (0.1 to 0.35 mg/kg). It. diminished responses to histamine, 5-HT, phenyldiguanide, and to a lesser extent, acetylcholine.

1967 ◽  
Vol 18 (01/02) ◽  
pp. 057-065 ◽  
Author(s):  
G Zbinden

SummaryIntravenous injection of 0.5% lauric acid solution into rabbits caused moderate to marked thrombocytopenia. With small doses (2.5 mg/kg) this thrombocyte decrease was reversible and microscopically demonstrable thrombosis in the lungs was only seen or suspected in a small number of rabbits 10 to 30 min after lauric acid injection. High doses were followed by partly reversible thrombocytopenia and by moderate to marked, sometimes lethal, thrombosis in the lungs still demonstrable 24 hrs after injection. Repeated administration of small doses of lauric acid did not lead to a depletion of the circulating thrombocytes. Thrombocytopenic response, however, appeared to be less pronounced after the second and subsequent injections. Studies with Cr51-labeled platelets indicate that during the reversible thrombocytopenia following a small intravenous dose of lauric acid platelets are retained in various organs, particularly the lungs.


1990 ◽  
Vol 259 (3) ◽  
pp. G355-G363 ◽  
Author(s):  
M. F. Otterson ◽  
S. K. Sarna

We studied the small intestinal motor effects of oral and intravenous (iv) erythromycin in 10 conscious dogs. After control recordings with placebo, oral or iv erythromycin was given at 40% of the migrating motor complex (MMC) cycle. Recordings were made after administration until normal contractile activity had returned or 12 h postdrug administration. Low doses initiated a premature MMC. High doses, however, prolonged the MMC cycle length. Erythromycin reduced the MMC propagation velocity at all doses. Both oral and iv erythromycin induced amyogenesia. During this pattern, electrical control activity was obliterated in the proximal and destabilized in the distal small intestine. Erythromycin also increased the incidence of retrograde giant contractions (RGCs) and vomiting. These effects occurred within the first 2 h after oral and within the first 30 min after iv administration. The incidence of giant migrating contractions (GMCs) increased significantly from 5 to 12 h but not from 0 to 5 h after administration. The distance of origination of GMCs from the ileocolonic junction was significantly increased from 5 to 12 h. The amplitude ratio, duration, and velocity of migration of GMCs induced after erythromycin were similar to control values. Clusters of coordinated antral and duodenal contractions also occurred early after administration. Our findings suggest that erythromycin has multiple motor effects on the stomach and small intestine. Diarrhea, abdominal cramping, and vomiting associated with erythromycin may be related to increased incidence of GMCs and RGCs. Erythromycin has a biphasic effect on MMC cycle length, initiating premature MMCs at low doses and prolonging their cycle length at higher doses.(ABSTRACT TRUNCATED AT 250 WORDS)


2002 ◽  
Vol 21 (2) ◽  
pp. 61-62 ◽  
Author(s):  
T Grune

The role of oxygen free radicals and other oxidants in several diseases has been well established over the past decade. Whereas it was long known that high doses of oxidants may damage or kill cells, the effect of low doses or long-time exposure to small flux rates of oxidants have been the focus of the free radical research until now. Here one has to take into account that most physiological and pathophysiological actions of oxidants and free radicals are based on the permanent action of small doses and flux rates. This includes effects of oxidants on signal transduction pathways and gene expression patterns. Therefore, only a few answers can be given today on the relevance of the effects of low doses of oxidants.


Ból ◽  
2018 ◽  
Vol 19 (2) ◽  
pp. 47-50
Author(s):  
Magdalena Skrzypacz

Naltrexone is a synthetic opioid that does not cause dependence. The substance is currently used in high doses - from 50-300 mg during the treatment of various addictions. A low dose of naltrexone (LDN) produces interesting antinociceptive results. Aim of the work is to draw attention to unregistered in Poland effect of small doses of this substance. In the presented case report of male K.N., 25 years old with diagnosed ankylosing spondylitis, an appropriate, restrictive diet, in accordance with the recommendations of the dietitian, in combination with low doses of naltrexone, turn out to be an effective analgesic therapy.


1966 ◽  
Vol 51 (2) ◽  
pp. 224-230 ◽  
Author(s):  
John A. Thomas ◽  
Edward T. Knych

ABSTRACT Norethynodrel antagonized the fructose stimulating effects of exogenous testosterone in sex accessory organs of castrate mice. It was antiandrogenic at both low doses (50 μg) and high doses (400 μg) of testosterone. Norethindrone and ethisterone suppressed fructose formation in the testosterone-treated castrate mouse, but not as effectively as norethynodrel. Norethandrolone exerted no antagonistic activity.


1969 ◽  
Vol 129 (3) ◽  
pp. 459-467 ◽  
Author(s):  
Norman W. Nisbet ◽  
Morten Simonsen ◽  
Marek Zaleski

Graft-vs.-host (GVH) reactions were performed in chicken embryos by intravenous injection of adult chicken blood dilutions, and the result was scored by weighing the spleens as well as by karyological identification of host and donor metaphases. From the frequency of detectable signs of GVH reaction when low doses of donor cells were injected into hosts containing one foreign allele of the B locus it is concluded that 1–2% must be a minimum estimate for the frequency of antigen-sensitive cells of a given specificity in this system. It is not found possible to reconcile the findings with the strictest form of clonal selection which postulates a single receptor specificity per clone of antigen-sensitive cells.


1983 ◽  
Vol 36 (4) ◽  
pp. 333 ◽  
Author(s):  
A RJones

Non-steroidal chemicals that affect male fertility have been known for over 25 years but only one compound, oc-chlorohydrin, possesses most of the attributes of an ideal male contraceptive. In the male rat, for example, continuous daily oral administration of low doses produces an almost immediate and continuous antifertility response that ceases when treatment is withdrawn. Such a dose regime does not interfere with libido, is apparently not toxic and the action is specific towards mature sperm. Furthermore, the action of the compound is species-specific: it is effective in the rat, ram, boar, guinea pig, hamster,rhesus monkey and upon ejaculated human sperm but it is ineffective in the mouse and the rabbit. High doses of oc-chlorohydrin can be neurotoxic, nephrotoxic and, in rats, lead to prolonged or permanent infertility. However, the antifertility response and the toxicity of racemic oc-chlorohydrin may be due, respectively, to the separate enantiomers. No other antifertility chemical has been investigated to such an extent as oc-chlorohydrin; this article reviews the progress that has been achieved with oc-chlorohydrin during the past six years.


2020 ◽  
Vol 7 ◽  
Author(s):  
Cihan Zamur ◽  
Uğur Topal

Decitabine (5-aza-2p-deoxycytidine) is a hypomethylation agent with a double-action mechanism, these are the reactivation of silenced genes; exhibiting differentiation at low doses and showing cytotoxicity at high doses. Decitabine was used as a classic anticancer drug in the original studies in the 1980s, 1500 to 2500 mg/m2 per cycle was the maximum clinically tolerated dose. The dosage was reassessed after a better understanding of epigenetics in cancer and the role of decitabine in epigenetic (hypomethylation) therapy was obtained, in about 1/20th of the previous doses (i.e., 'optimal biological' doses modulating hypomethylation). It has been found that decitabine (100 to 150 mg / m2 per cycle) can be used in patients with myelodysplastic syndromes (MDS) and other myeloid tumors, with manageable side effects. Combination therapies which amplify the epigenetic effect of decitabine will most likely improve the patient responses and allow it to be used in the treatment of other malignancies.


Sign in / Sign up

Export Citation Format

Share Document